Calton & Associates, Inc. Adaptive Biotechnologies Corp Transaction History

Calton & Associates, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$3.46 - $5.33 $82,282 - $126,752	23,781 New	23,781 $116,000
Q2 2023 Jul 24, 2023	SELL	$6.19 - $8.78 $3,299 - $4,679	-533 Reduced 3.66%	14,020 $94,000
Q1 2023 Apr 19, 2023	BUY	$7.8 - $10.11 $2,090 - $2,709	268 Added 1.88%	14,553 $128,000
Q4 2022 Jan 18, 2023	BUY	$6.26 - $9.34 $24,182 - $36,080	3,863 Added 37.07%	14,285 $0
Q3 2022 Oct 31, 2022	SELL	$6.5 - $12.67 $1,761 - $3,433	-271 Reduced 2.53%	10,422 $74,000
Q2 2022 Jul 12, 2022	SELL	$6.4 - $14.73 $4,236 - $9,751	-662 Reduced 5.83%	10,693 $86,000
Q1 2022 Apr 12, 2022	BUY	$10.12 - $28.9 $114,912 - $328,159	11,355 New	11,355 $157,000
Q1 2021 May 03, 2021	SELL	$37.26 - $67.74 $139,128 - $252,941	-3,734 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$45.01 - $65.47 $168,067 - $244,464	3,734 New	3,734 $221,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.